Dr. Hans-Georg Eichler, will be retiring next month from his current position of Senior Medical Officer of the European Medicines Agency (EMA). After his retirement, he will be co-leading the development of an invited publication for Clinical Pharmacology and Therapeutics (CP&T) focused on the role of RWE in access and reimbursement decisions for personalized medicines. This important article will advance themes initially elucidated in our collaboration with Dr. Eichler, former Visiting Scholar at MIT, in the NEWDIGS Adaptive Licensing Project (2011-2013).